Goldwind Science & Technology (02208) has repurchased a total of 10,000 H shares.
Golden Wind Technology (02208) announced the progress of share buybacks. As of March 31, 2026, the company has not repurchased any A shares. The company first repurchased H shares on January 6, 2026. As of March 31, 2026, the company has repurchased a total of 10,000 H shares (approximately 0.0002% of the total share capital), with the highest repurchase price at 14.510 Hong Kong dollars per share, the lowest price at 14.500 Hong Kong dollars per share, and the average transaction price at 14.505 Hong Kong dollars per share. The total transaction amount (excluding transaction fees) is 145.05 thousand Hong Kong dollars.
Goldwind Science & Technology (02208) announced the progress of share buyback. As of March 31, 2026, the company has not repurchased any A shares. The company first repurchased H shares on January 6, 2026, and as of March 31, 2026, the company has repurchased a total of 10,000 H shares (approximately 0.0002% of the total share capital). The highest price at which the repurchase was conducted was HK$14.510 per share, the lowest price was HK$14.500 per share, and the average price was HK$14.505 per share. The total transaction amount (excluding transaction fees) was HK$145,050.
Related Articles
NEWAY GROUP (00055): Zhang Yushan appointed as the new company secretary.
GLORIOUS PPT H(00845): Property units selling and delivering total construction area exceeding 70,000 square meters in 2025.
SINOMAB BIO-B (03681): The first patient in China with atopic dermatitis completes Phase 2 clinical trial of SM17 treatment.
NEWAY GROUP (00055): Zhang Yushan appointed as the new company secretary.
GLORIOUS PPT H(00845): Property units selling and delivering total construction area exceeding 70,000 square meters in 2025.
SINOMAB BIO-B (03681): The first patient in China with atopic dermatitis completes Phase 2 clinical trial of SM17 treatment.
